Nectar AFBV Komplementar ApS: Financial statements 2023
CVR: 43862189
Nectar AFBV Komplementar ApS (CVR 43862189) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -13,170 and a net result of DKK 9,234. Equity amounted to DKK 49,234. The solvency ratio was 86.6%. The company had 1 employee in the financial year.
- Gross Profit
- -13,170 kr.
- Profit/Loss
- 9,234 kr.
- Equity
- 49,234 kr.
- Total Assets
- 56,830 kr.
- Employees
- 1
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of March 20, 2023, PharmaService I/S is registered as an owner of Nectar AFBV Komplementar ApS with an ownership share of 90%.
As of February 15, 2023, Bjørk Krogshave is registered as director of Nectar AFBV Komplementar ApS.
Nectar AFBV Komplementar ApS was founded on February 15, 2023.
About Nectar AFBV Komplementar ApS
Nectar AFBV Komplementar ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Bjørk Krogshave. The company is owned by Torben Kjergaard Madsen and PharmaService I/S. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK 15,177 compared with DKK 15,401 the year before. Equity amounted to DKK 79,812.
